利培酮合并氯氮平治疗难治性精神分裂症的对照研究  

A Control Study of Risperidone in Combination with Clozapine in Treating Refractory Schizophrenia

作　　者：彭红军[1] 邝如意[1] 黄雄 王玲芝[1] 朱福坚[1] 

机构地区：[1]广州市精神病医院,广州510370

出　　处：《现代临床医学生物工程学杂志》2001年第2期100-102,共3页Journal of Modern Clinical Medical Bioengineering

摘　　要：目的　探讨利培酮合并氯氮平治疗难治性精神分裂症的疗效及副作用 .方法　将 10 1例难治患者用配对半随机法分成利培酮组 (A)、氯氮平组 (B)及二药联用组 (AB) ,疗期 8周 ,用PANSS、CGI、TESS评定疗效及副作用 .结果三组 8周疗效相似 (p >0 .0 5 ) ,有效率A组 6 0 0 %、B组 6 1.8%、AB组 6 2 .5 % ;AB组与A组均于第一周起效 ,治疗 2周时AB组疗效较单用组佳 (p <0 .0 5 ) ,对阳性症状疗效突出 (p<0 .0 5 ) ;AB组副作用比单用组少 .结论　利培酮与氯氮平治疗难治性精神分裂症有效 。Objective To explore the efficacy and side effects of the combination therapy of risperidone and clozapine on refractory schizophrenia.Methods 101 cases with refractory schizophrenia matched in duration and types of disease were randomly divided into three groups (A, B and AB ) and treated with risperidone,clozapine and combined therapy respectively for 8 weeks. The efficacy and side effects were assessed with PANSS, CGI and TESS.Results There was no significant efficacy difference (p>0.05) among group AB(62.5%), group A(60.0%) and group B(61.8%) after 8 weeks treatment. Both group AB and group A responded at the first week, and the efficacy of group AB was superior to that of the other two groups (p<0.05) after 2 weeks, especially for positive symptoms(p<0.05). There were fewer side effects in group AB than the other two groups.Conclusions Risperidone was a effective treatment for refractory schizophrenia as well as Clozapine, and it could be a more safe and effective treatment if two drugs were used in combination.

关 键 词：利培酮 氯氮平 药物联合治疗 难治性精神分裂症 

分 类 号：R749.3[医药卫生—神经病学与精神病学] R971.41[医药卫生—临床医学]